Evaluation Study of Hypertension as a Predictor of Efficacy Bevacizumab (BV) in Combination With Chemotherapy (CT) in Metastatic Colorectal Cancer (MCC) and Metastatic Breast Cancer (MBC).
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Breast cancer; Colorectal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms BRECOL
- 31 Aug 2018 Biomarkers information updated
- 04 Jan 2013 New trial record
- 01 Nov 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.